Ordering
Available Variants5 mg
CHA.79248-5mg
Price
€109.48
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.79248-5mg | €109.48 |
Professionally catalogued chemical listing prepared to support identification, technical review, safety visibility, and structured B2B sourcing workflows.
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C21H20N4O3 |
|---|---|
| CAS Number | 32828-81-2 |
| Molecular Weight | 376.41 |
| NACRES | NA.83 |
| PubChem Substance ID | 24278656 |
| UNSPSC Code | 12352204 |
| EC Number | 251-245-7 |
| MDL number | MFCD00866792 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 2 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Picotamide, with a chemical formula of C18H20N4O3S and a CAS number of 32828-81-2, is a dual inhibitor of thromboxane A2 synthase and a thromboxane A2 receptor antagonist. This compound has been investigated for its potential therapeutic applications in the prevention and treatment of thrombotic disorders, such as myocardial infarction and stroke. Picotamides mechanism of action involves the inhibition of thromboxane A2 production, which is a potent vasoconstrictor and platelet aggregator, thereby reducing the risk of thrombotic events. Studies have demonstrated that picotamide exhibits anti-thrombotic activity without significantly affecting bleeding time, suggesting its potential as a safe and effective anti-thrombotic agent. Further research is needed to fully elucidate the clinical efficacy and safety of picotamide in various patient populations.
